Jeffrey A Johnson

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated
    Jeffrey A Johnson
    Laboratory Branch, National Center for HIV, STD, and Tuberculosis Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 192:16-23. 2005
  2. ncbi Simple PCR assays improve the sensitivity of HIV-1 subtype B drug resistance testing and allow linking of resistance mutations
    Jeffrey A Johnson
    Laboratory Branch, Division of HIV ADS Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
    PLoS ONE 2:e638. 2007
  3. ncbi Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy
    Jeffrey A Johnson
    Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
    PLoS Med 5:e158. 2008
  4. ncbi Alpha interferon augments cidofovir's antiviral and antiproliferative activities
    Jeffrey A Johnson
    Department of Microbiology and Molecular Medicine and the Greenville Hospital System Biomedical Cooperative, Clemson University, Clemson, South Carolina 29634, USA
    Antimicrob Agents Chemother 47:2022-6. 2003
  5. ncbi Expression of a recombinant gag protein from endogenous avian virus and its use in screening for antibody reactivity in recipients of chick-derived vaccines
    Jeffrey A Johnson
    HIV and Retrovirology Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Vaccine 21:3738-45. 2003
  6. ncbi Low-frequency HIV-1 drug resistance mutations can be clinically significant but must be interpreted with caution
    Jeffrey A Johnson
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    J Antimicrob Chemother 65:1322-6. 2010
  7. ncbi Detection of low-level K65R variants in nucleoside reverse transcriptase inhibitor-naive chronic and acute HIV-1 subtype C infections
    Jin fen Li
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Infect Dis 203:798-802. 2011
  8. ncbi Addition of 7 days of zidovudine plus lamivudine to peripartum single-dose nevirapine effectively reduces nevirapine resistance postpartum in HIV-infected mothers in Malawi
    Sherry L Farr
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30345, USA
    J Acquir Immune Defic Syndr 54:515-23. 2010
  9. ncbi A rapid and sensitive real-time PCR assay for the K65R drug resistance mutation in SIV reverse transcriptase
    Jeffrey A Johnson
    National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30303, USA
    AIDS Res Hum Retroviruses 22:912-6. 2006
  10. ncbi Minority HIV mutation detection in dried blood spots indicates high specimen integrity and reveals hidden archived drug resistance
    Xierong Wei
    Laboratory Branch, Division of HIV AIDS Prevention, National Centers for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd, NE, MS G45 Atlanta, GA 30333, USA
    J Clin Virol 50:148-52. 2011

Collaborators

Detail Information

Publications38

  1. ncbi Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated
    Jeffrey A Johnson
    Laboratory Branch, National Center for HIV, STD, and Tuberculosis Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 192:16-23. 2005
    ..These findings indicate that resistance mutations emerged in at least 65% of the women after SD-NVP and emphasize the importance of further research to determine the clinical implications...
  2. ncbi Simple PCR assays improve the sensitivity of HIV-1 subtype B drug resistance testing and allow linking of resistance mutations
    Jeffrey A Johnson
    Laboratory Branch, Division of HIV ADS Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
    PLoS ONE 2:e638. 2007
    ..Sensitive detection of drug-resistant subpopulations, however, requires simple and practical methods for routine testing...
  3. ncbi Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy
    Jeffrey A Johnson
    Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
    PLoS Med 5:e158. 2008
    ..We used sensitive and simple tests to investigate evidence of transmitted drug resistance in antiretroviral drug-naïve persons and assess the clinical implications of minority drug-resistant variants...
  4. ncbi Alpha interferon augments cidofovir's antiviral and antiproliferative activities
    Jeffrey A Johnson
    Department of Microbiology and Molecular Medicine and the Greenville Hospital System Biomedical Cooperative, Clemson University, Clemson, South Carolina 29634, USA
    Antimicrob Agents Chemother 47:2022-6. 2003
    ..Evaluation of effective drug ratios revealed a synergistic cooperation between IFN-alpha 2a and cidofovir in inhibiting the proliferation of HPV-infected cells...
  5. ncbi Expression of a recombinant gag protein from endogenous avian virus and its use in screening for antibody reactivity in recipients of chick-derived vaccines
    Jeffrey A Johnson
    HIV and Retrovirology Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Vaccine 21:3738-45. 2003
    ..The results support a lack of EAV infection in the vaccine recipients...
  6. ncbi Low-frequency HIV-1 drug resistance mutations can be clinically significant but must be interpreted with caution
    Jeffrey A Johnson
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    J Antimicrob Chemother 65:1322-6. 2010
    ..Paramount to interpreting the clinical utility of sensitive testing is evaluating resistance mutations selectively, at biologically significant frequencies, and using methods that have been broadly validated on clinical specimens...
  7. ncbi Detection of low-level K65R variants in nucleoside reverse transcriptase inhibitor-naive chronic and acute HIV-1 subtype C infections
    Jin fen Li
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Infect Dis 203:798-802. 2011
    ..The frequent appearance of subtype C frameshift deletions at codon 65 supports a propensity for transcription error in this region...
  8. ncbi Addition of 7 days of zidovudine plus lamivudine to peripartum single-dose nevirapine effectively reduces nevirapine resistance postpartum in HIV-infected mothers in Malawi
    Sherry L Farr
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30345, USA
    J Acquir Immune Defic Syndr 54:515-23. 2010
    ..We assessed whether 7 days of zidovudine + lamivudine postpartum with single-dose nevirapine at labor decreases nevirapine resistance in HIV-infected women in Malawi...
  9. ncbi A rapid and sensitive real-time PCR assay for the K65R drug resistance mutation in SIV reverse transcriptase
    Jeffrey A Johnson
    National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30303, USA
    AIDS Res Hum Retroviruses 22:912-6. 2006
    ..4% and 3%, below the detection capability of population sequencing. We propose the SIV K65R real-time PCR assay provides improved sensitivity and simplicity in studying tenofovir resistance in macaque models...
  10. ncbi Minority HIV mutation detection in dried blood spots indicates high specimen integrity and reveals hidden archived drug resistance
    Xierong Wei
    Laboratory Branch, Division of HIV AIDS Prevention, National Centers for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd, NE, MS G45 Atlanta, GA 30333, USA
    J Clin Virol 50:148-52. 2011
    ..Dried blood spots (DBS) could serve as an attractive, cost-effective alternative to plasma for HIV drug resistance testing...
  11. ncbi Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir
    J Gerardo Garcia-Lerma
    Division of HIV AIDS Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    PLoS Med 5:e28. 2008
    ..We evaluated daily and intermittent PrEP regimens of increasing antiviral activity in a macaque model that closely resembles human transmission...
  12. ncbi Identification and characterization of avian retroviruses in chicken embryo-derived yellow fever vaccines: investigation of transmission to vaccine recipients
    Althaf I Hussain
    HIV and Retrovirology Branch, Division of AIDS, STD, and TB Laboratory Research, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Virol 77:1105-11. 2003
    ..The absence of evidence of infection with ALV-E or EAV in 43 YF vaccine recipients suggests low risks for transmission of these viruses, further supporting the safety of these vaccines...
  13. ncbi Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana
    Michael C Thigpen
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, USA
    N Engl J Med 367:423-34. 2012
    ..Preexposure prophylaxis with antiretroviral agents has been shown to reduce the transmission of human immunodeficiency virus (HIV) among men who have sex with men; however, the efficacy among heterosexuals is uncertain...
  14. ncbi Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006
    William H Wheeler
    Division of HIV AIDS Prevention, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS 24:1203-12. 2010
    ..To determine the distribution of HIV-1 subtypes and the prevalence of transmitted drug resistance-associated mutations (TDRM) among persons newly diagnosed with HIV-1 infection in the United States...
  15. ncbi Physical activity levels and differences in the prevalence of diabetes between the United States and Canada
    Xuanping Zhang
    Division of Diabetes Translation, Centers for Disease Control and Prevention, 4770 Buford Highway NE, Atlanta, GA 30341, USA
    Prev Med 50:241-5. 2010
    ..To examine the American-Canadian difference in physical activity and its association with diabetes prevalence...
  16. ncbi Structured treatment interruptions with tenofovir monotherapy for simian immunodeficiency virus-infected newborn macaques
    Koen K A Van Rompay
    California National Primate Research Center, University of California, Davis, CA 95616, USA
    J Virol 80:6399-410. 2006
    ....
  17. ncbi Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection
    Koen K A Van Rompay
    California National Primate Research Center, University of California, Davis, USA
    Retrovirology 4:25. 2007
    ..Accordingly, to model HIV-1 RT responses, 12 macaques were inoculated with RT-SHIV, a chimeric SIV containing HIV-1 RT, and started on prolonged tenofovir therapy 5 months later...
  18. ncbi Type of antidepressant therapy and risk of type 2 diabetes in people with depression
    Lauren C Brown
    School of Public Health, University of Alberta, Edmonton, Alberta, Canada
    Diabetes Res Clin Pract 79:61-7. 2008
    ..The objective of this study was to evaluate the differential risk of diabetes among people with depression taking antidepressant therapy...
  19. ncbi Physical activity level and health-related quality of life in the general adult population: a systematic review
    Raphael Bize
    Centre for Health Promotion Studies, School of Public Health, University of Alberta, Edmonton, Canada
    Prev Med 45:401-15. 2007
    ..Little is known regarding health-related quality of life and its relation with physical activity level in the general population. Our primary objective was to systematically review data examining this relationship...
  20. ncbi Role of Nrf2-dependent ARE-driven antioxidant pathway in neuroprotection
    Jiang Li
    School of Pharmacy, University of Wisconsin, Madison, USA
    Methods Mol Biol 399:67-78. 2007
    ..The details for generating Nrf2-overexpressing astrocytes and grafting them onto the lesion model are described in this chapter...
  21. ncbi How evidence-based are the recommendations in evidence-based guidelines?
    Finlay A McAlister
    The Division of General Internal Medicine, University of Alberta, Edmonton, Canada
    PLoS Med 4:e250. 2007
    ..This study was done to evaluate the quality of the evidence (based on consideration of its internal validity, clinical relevance, and applicability) underlying therapy recommendations in evidence-based clinical practice guidelines...
  22. ncbi Development of oxidative stress by cytochrome P450 induction in rodents is selective for barbiturates and related to loss of pyridine nucleotide-dependent protective systems
    Miroslav Dostalek
    Department of Biochemistry, Division of Clinical Pharmacology, and Center in Molecular Toxicology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232 0146, USA
    J Biol Chem 283:17147-57. 2008
    ..These multiple effects on the protective systems are proposed to be more important than P450 induction in oxidative stress and emphasize the importance of studying in vivo models...
  23. ncbi Accelerated Abeta deposition in APPswe/PS1deltaE9 mice with hemizygous deletions of TTR (transthyretin)
    Se Hoon Choi
    Committee on Neurobiology, University of Chicago, Chicago, Illinois 60637, USA
    J Neurosci 27:7006-10. 2007
    ..Moreover, Abeta deposition is significantly accelerated in the hippocampus and cortex of ceAPPswe/PS1deltaE9/TTR+/- mice. Our results strongly suggest that TTR plays a critical role in modulating Abeta deposition in vivo...
  24. ncbi The natural history of LDL control in type 2 diabetes: a prospective study of adherence to lipid guidelines
    Diana Rucker
    University of Alberta, 2E3.07 Walter Mackenzie Health Sciences Centre, University of Alberta Hospital, 8440-112th St, Edmonton, Alberta, Canada
    Diabetes Care 29:2506-8. 2006
  25. ncbi Dialysis adequacy and health related quality of life in hemodialysis patients
    Braden J Manns
    Department of Medicine, University of Calgary, Alberta, Canada
    ASAIO J 48:565-9. 2002
    ..Dialysis adequacy was significantly associated with HRQOL in hemodialysis patients. Controlled studies that examine the effect of increasing Kt/V on HRQOL are needed...
  26. ncbi Shifting from inpatient to outpatient treatment of deep vein thrombosis in a tertiary care center: a cost-minimization analysis
    Michel Boucher
    Department of Pharmacy, Ottawa Hospital, Ontario, Canada
    Pharmacotherapy 23:301-9. 2003
    ..Accordingly, it is financially advantageous for hospitals to offer this service as it reduces direct costs and does not appear to compromise patient care...
  27. ncbi Genetic programming by the proteolytic fragments of the amyloid precursor protein: somewhere between confusion and clarity
    Thor D Stein
    Neuroscience Training Program, University of Wisconsin, Madison, WI 53705-2222, USA
    Rev Neurosci 14:317-41. 2003
    ..In fact, the gene expression changes driven by sAPPalpha, such as increases in transthyretin and insulin-like growth factor 2, may protect these mice from high levels of Abeta...
  28. ncbi A comparison of the health utilities indices Mark 2 and Mark 3 in type 2 diabetes
    Sheri L Maddigan
    Department of Public Health Sciences, University of Alberta, Edmonton, Canada
    Med Decis Making 23:489-501. 2003
    ....
  29. ncbi Construct validity of the RAND-12 and Health Utilities Index Mark 2 and 3 in type 2 diabetes
    Sheri L Maddigan
    Department of Public Health Sciences, University of Alberta, Edmonton, Canada
    Qual Life Res 13:435-48. 2004
    ..The results of this study contribute evidence of construct validity of the HUI2, HUI3 and RAND-12 in type 2 diabetes...
  30. ncbi Targeted disruption of Nrf2 causes regenerative immune-mediated hemolytic anemia
    Jong Min Lee
    School of Pharmacy, Molecular and Environmental Toxicology Center, University of Wisconsin, Madison, WI 53705, USA
    Proc Natl Acad Sci U S A 101:9751-6. 2004
    ....
  31. ncbi Lack of insurance coverage for testing supplies is associated with poorer glycemic control in patients with type 2 diabetes
    Samantha L Bowker
    Institute of Health Economics, Edmonton, AB
    CMAJ 171:39-43. 2004
    ..5%, p = 0.006). INTERPRETATION: Patients without insurance for self-monitoring test strips had poorer glycemic control...
  32. ncbi History of depression increases risk of type 2 diabetes in younger adults
    Lauren C Brown
    Department of Public Health Sciences, University of Alberta, 1200-10405 Jasper Avenue, Edmonton, Alberta, Canada T5J 3N4
    Diabetes Care 28:1063-7. 2005
    ..92 [0.84-1.00]). CONCLUSIONS: Depression appears to increase the risk of developing diabetes by approximately 23% in younger adults. This provides information regarding the temporality of the relationship between diabetes and depression...
  33. ncbi A cross-sectional study of health-related quality of life deficits in individuals with comorbid diabetes and cancer
    Samantha L Bowker
    Department of Public Health Sciences, Faculty of Medicine and Dentistry, University of Alberta, 13 103 Clinical Sciences Building, Edmonton, Alberta, T6G 2G3, Canada
    Health Qual Life Outcomes 4:17. 2006
    ..We assessed the HRQL burden in patients with these comorbid conditions, postulating that they would have even greater HRQL deficits...
  34. ncbi Health Utilities Index mark 3 demonstrated construct validity in a population-based sample with type 2 diabetes
    Sheri L Maddigan
    Department of Public Health Sciences, University of Alberta, Edmonton, Alberta, Canada
    J Clin Epidemiol 59:472-7. 2006
    ..Overall HUI3 scores were significantly predictive of all three categories of health-care resource use. CONCLUSION: Observed differences between groups contribute further evidence of the construct validity of the HUI3 in type 2 diabetes...
  35. ncbi Nrf transcription factors in keratinocytes are essential for skin tumor prevention but not for wound healing
    Ulrich auf dem Keller
    Institute of Cell Biology, Department of Biology, ETH Zurich, Honggerberg, HPM D42, CH 8093 Zurich, Switzerland
    Mol Cell Biol 26:3773-84. 2006
    ....
  36. ncbi Longitudinal validation of a modified Edmonton symptom assessment system (ESAS) in haemodialysis patients
    Sara N Davison
    Division of Nephrology and Immunology, Department of Public Health Sciences, Institute of Health Economics, University of Alberta, Edmonton, Canada, T6G 2G3
    Nephrol Dial Transplant 21:3189-95. 2006
    ..This study examines the longitudinal validity of the modified Edmonton symptom assessment system (ESAS) to determine the impact of change in symptom burden on the change in HRQL of haemodialysis (HD) patients...
  37. ncbi Electrophilic chemicals but not UV irradiation or reactive oxygen species activate Nrf2 in keratinocytes in vitro and in vivo
    Moritz Durchdewald
    Department of Biology, Institute of Cell Biology, ETH Zurich, Zurich, Switzerland
    J Invest Dermatol 127:646-53. 2007
    ..Electrophiles but not UVB activated the reporter in an Nrf2-dependent manner. These results provide the basis for the identification of novel Nrf2 activators in keratinocytes with therapeutic potential for skin tumor prevention...
  38. ncbi Development and validation of a survey to assess barriers to drug use in patients with chronic heart failure
    Scot H Simpson
    Institute of Health Economics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada
    Pharmacotherapy 22:1163-72. 2002
    ..Conclusion. The BMU survey demonstrated reasonable reliability and validity characteristics in this first clinical experience. Despite high adherence, patients still reported barriers that may hinder optimal drug use...